Analysis of Antibody Neutralization Efficiency, Seroprevalence and Long Term Immunity in SARS-CoV-2-Positive Individuals Identified in a Surveillance Survey of At-Risk Individuals
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 202012GSM
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$13,125Funder
Canadian Institutes of Health Research (CIHR)Research Location
CanadaLead Research Institution
University of OttawaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
Vulnerable populations unspecifiedOccupations of Interest
Unspecified